This is a treatment result comparison between two groups of breast cancer patients.

Patients in control group receive chemotherapy only. Patients in comparison group receive chemotherapy and immunotherapy.

Significant rising of lymphocyte (CD3+), helper T cells (CD3+/CD4+), NK cells (CD3-/CD16+56+) and NKT cells was observed 7 days after the treatment with DC-CIK immunotherapy. In contrast, suppressor T cells decreased. These indicated remarkable improvement on immune response of patients in comparison group.

None of these was observed in the test result from patients in the control group.